Goldman Sachs Upgrades Hologic (HOLX) to Conviction Buy (Dec 7)
Tweet Send to a Friend
Goldman Sachs upgraded Hologic (NASDAQ: HOLX) from Buy to Conviction Buy with a price target of $50.00.Analyst Jami Rubin added ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
